- Published on
Infectious Disease and Microbiology – E. coli Infections
Escherichia coli are Gram-negative, rod-shaped bacteria that are part of the normal intestinal flora but can also cause a wide range of infections. They are among the most important pathogens in both community-acquired and hospital-acquired infections.
Epidemiologically, E. coli is the leading cause of nosocomial bacteremia and is responsible for more than 80% of acute uncomplicated urinary tract infections in young women. It is also a major cause of traveler’s diarrhea, typically acquired via the fecal–oral route through contaminated food or water, especially in tropical and subtropical regions. Urinary tract infections often occur due to colonization of the periurethral area followed by ascending infection. Risk factors in women include sexual activity and use of spermicides or diaphragms. In men, risks include lack of circumcision, anal intercourse, and exposure to colonized partners. Immunocompromised individuals, including those with HIV (especially CD4 <200), are also at increased risk.
Additional risk factors include anatomical abnormalities such as urinary obstruction or stones, immunosuppression (e.g., diabetes, malignancy, steroid use), and certain host susceptibility factors such as inability to secrete blood group antigens, which facilitates bacterial adherence. Preventive strategies include careful use of antibiotic prophylaxis in selected travelers and avoiding unnecessary screening for asymptomatic bacteriuria except in specific groups such as pregnant women.
The pathophysiology of E. coli infections is based on its ability to adhere to host cells and produce toxins. Different strains have distinct pathogenic mechanisms. Enterotoxigenic E. coli (ETEC) produces toxins that increase cyclic nucleotide levels, leading to increased chloride secretion and watery diarrhea. Enteropathogenic strains disrupt intestinal mucosa, especially in children. Enteroinvasive strains invade intestinal cells, causing inflammatory diarrhea. Enterohemorrhagic E. coli (EHEC), such as O157:H7, produces Shiga toxin and can cause hemorrhagic colitis and hemolytic–uremic syndrome, often associated with contaminated beef or dairy products. Enteroaggregative strains are linked to persistent diarrhea, particularly in travelers and immunocompromised patients.
Uropathogenic E. coli strains possess specific virulence factors, including pili that allow adherence to uroepithelial cells, leading to infections ranging from cystitis to pyelonephritis and even septicemia. Beyond the urinary and gastrointestinal systems, E. coli can cause intra-abdominal infections such as abscesses, cholecystitis, and cholangitis. It is also associated with serious conditions including meningitis in neonates, as well as endocarditis, pneumonia, osteomyelitis, septic arthritis, and other systemic infections.
Diagnosis is confirmed by isolating E. coli from normally sterile sites such as blood, cerebrospinal fluid, or bile. In diarrheal illness, specialized testing such as PCR or toxin detection may be required to identify specific pathogenic strains. Imaging studies like abdominal CT or ultrasound may help identify complications such as abscesses or hepatobiliary infections. The differential diagnosis depends on the clinical presentation and includes other bacterial causes such as Campylobacter, Salmonella, and Shigella, particularly in cases of bloody diarrhea.
Treatment depends on the type and severity of infection. Localized infections require both antimicrobial therapy and, when necessary, drainage of abscesses or removal of infected material. Traveler’s diarrhea is commonly treated with short courses of fluoroquinolones or trimethoprim–sulfamethoxazole, along with supportive therapy such as hydration and antidiarrheal agents. However, antibiotics are generally avoided in EHEC infections due to the risk of worsening toxin-mediated complications such as hemolytic–uremic syndrome.
Uncomplicated cystitis is treated with short courses of oral antibiotics, while pyelonephritis requires longer treatment and sometimes hospitalization for intravenous therapy. Severe infections such as bacteremia or sepsis require broad-spectrum intravenous antibiotics, including fluoroquinolones, third-generation cephalosporins, or carbapenems. Pregnant patients require specific antibiotic choices such as penicillins, cephalosporins, or nitrofurantoin.
Follow-up is important in patients with persistent bacteremia or recurrent infections, as these may indicate underlying abnormalities such as abscesses, urinary tract obstruction, or foreign bodies. Prognosis is generally good with appropriate treatment, although complications such as dehydration, septic shock, and hemolytic–uremic syndrome can occur. Severe systemic infections may be life-threatening, particularly in vulnerable populations such as those with liver disease, immunosuppression, or impaired immune function.
0 Comments
